Home / Companies / Zumutor Biologics

Zumutor Biologics

Biotechnology / Immuno-oncologyBengaluru, Karnataka, India

Zumutor Biologics is an Indian biotechnology company developing antibody-based cancer immunotherapies. Its lead candidate targets the LAIR1 immune checkpoint pathway, and the company has pursued United States clinical development for its oncology programmes.

1StartupFox story
2012Founded
Biotechnology / Immuno-oncologySector
Jun 2026Latest coverage
Latest on Zumutor Biologics
Funding
Zumutor Biologics Raises $7.3 Million Pre-Series B to Advance US FDA Cancer Trials
15 JUN 2026 · 4 MIN READ
Also in Health & Bio
VeticPet Healthcare / VeterinaryImmuneel TherapeuticsBiotechnology / Cell TherapyHoola HealthHealthcare / Paediatric ClinicsBiodimensionLife Sciences / Biofabrication
Frequently Asked
What is Zumutor Biologics?
Zumutor Biologics is an Indian biotechnology company developing antibody-based cancer immunotherapies. Its lead candidate targets the LAIR1 immune checkpoint pathway, and the company has pursued United States clinical development for its oncology programmes.
Who founded Zumutor Biologics?
Zumutor Biologics is associated with Kavitha Iyer Rodrigues.
What is the latest news on Zumutor Biologics?
The most recent StartupFox coverage is “Zumutor Biologics Raises $7.3 Million Pre-Series B to Advance US FDA Cancer Trials” (15 June 2026). All stories are listed on this page.